PerkinElmer (NYSE: PKI) reported earnings on April 26. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended April 1 (Q1), PerkinElmer met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded and GAAP earnings per share contracted.

Gross margins improved, operating margins shrank, and net margins dropped.

Revenue details
PerkinElmer recorded revenue of $510.9 million. The 11 analysts polled by S&P Capital IQ expected a top line of $509.7 million on the same basis. GAAP reported sales were 14% higher than the prior-year quarter's $447.9 million.

My

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.43. The 13 earnings estimates compiled by S&P Capital IQ forecast $0.41 per share. GAAP EPS of $0.19 for Q1 were 5.0% lower than the prior-year quarter's $0.20 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 45.4%, 70 basis points better than the prior-year quarter. Operating margin was 8.3%, 120 basis points worse than the prior-year quarter. Net margin was 4.4%, 90 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $544.2 million. On the bottom line, the average EPS estimate is $0.49.

Next year's average estimate for revenue is $2.18 billion. The average EPS estimate is $2.03.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 123 members out of 136 rating the stock outperform, and 13 members rating it underperform. Among 36 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 34 give PerkinElmer a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on PerkinElmer is outperform, with an average price target of $29.50.